Skip to main content
Erschienen in: The International Journal of Cardiovascular Imaging 5/2018

22.11.2017 | Original Paper

Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study

verfasst von: Yue Zhong, Wenjuan Bai, Qibing Xie, Jianhong Sun, Hong Tang, Li Rao

Erschienen in: The International Journal of Cardiovascular Imaging | Ausgabe 5/2018

Einloggen, um Zugang zu erhalten

Abstract

Cardiac event is a major cause of death in patients with idiopathic inflammatory myopathies (IIM). The most frequent IIMs are polymyositis (PM) and dermatomyositis (DM). The purpose of this study was to analyze cardiac involvement by three-dimensional speckle-tracking echocardiography (3D STE) in patients with PM or DM, and to identify the relationship of cardiac injury with clinical characteristics and disease-specific parameters. 60 PM/DM patients with preserved left ventricular ejection fraction and 30 matched healthy controls were assessed by conventional echocardiography, 3D STE with biventricular strain analysis and electrocardiogram. Compared to controls, patients with PM/DM had significantly diminished left ventricular global longitudinal systolic strain and right ventricular longitudinal systolic strain (LVGLS, − 20.3 ± 2.5 vs. − 23.4 ± 1.7%; RVLS, − 19.4 ± 4.2 vs − 24.8 ± 2.0%; both P < 0.001), and longer QTc intervals(421.0 ± 38.4 vs 400.6 ± 14.5 ms, P = 0.001). Multiple regression analysis showed that Myositis Damage Index (MDI) was independently associated with LVGLS (R2 = 0.44, P = 0.002) and RVLS (R2 = 0.56, P < 0.001) in PM/DM patients with established disease course more than 1 year. In multivariate analysis of pooled data for all the PM/DM patients, when MDI was excluded due to missing observations, disease duration correlated with worse LVGLS (R2 = 0.24, P = 0.002), while concomitant interstitial lung disease correlated with worse RVLS (R2 = 0.30, P < 0.001). Disease activity scores (Myositis Intention to Treat Activities Index) had a weak positive correlation with QTc intervals (rsp = 0.31, P = 0.02). Our results suggest that cardiac injury in PM/DM is a long-term process and its severity depends on patients’ heterogeneous clinical features and systemic disease burden.
Literatur
1.
Zurück zum Zitat Torres C, Belmonte R, Carmona L, Gómez-Reino FJ, Galindo M, Ramos B et al (2006) Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity 39:205–215CrossRefPubMed Torres C, Belmonte R, Carmona L, Gómez-Reino FJ, Galindo M, Ramos B et al (2006) Survival, mortality and causes of death in inflammatory myopathies. Autoimmunity 39:205–215CrossRefPubMed
2.
Zurück zum Zitat Marie I (2012) Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 14:275–285CrossRefPubMed Marie I (2012) Morbidity and mortality in adult polymyositis and dermatomyositis. Curr Rheumatol Rep 14:275–285CrossRefPubMed
3.
Zurück zum Zitat Zhang L, Wang GC, Ma L, Zu N (2012) Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol 35:685–691CrossRef Zhang L, Wang GC, Ma L, Zu N (2012) Cardiac involvement in adult polymyositis or dermatomyositis: a systematic review. Clin Cardiol 35:685–691CrossRef
4.
Zurück zum Zitat Wang H, Liu HX, Wang YL, Yu XQ, Chen XX, Cai L (2014) Left ventricular diastolic dysfunction in patients with dermatomyositis without clinically evident cardiovascular disease. J Rheumatol 41:495–500CrossRefPubMed Wang H, Liu HX, Wang YL, Yu XQ, Chen XX, Cai L (2014) Left ventricular diastolic dysfunction in patients with dermatomyositis without clinically evident cardiovascular disease. J Rheumatol 41:495–500CrossRefPubMed
5.
Zurück zum Zitat Diederichsen LP, Simonsen JA, Diederichsen AC, Hvidsten S, Hougaard M, Junker P (2016) Cardiac abnormalities in adult patients with polymyositis or dermatomyositis as assessed by noninvasive modalities. Arthritis Care Res 68:1012–1020CrossRef Diederichsen LP, Simonsen JA, Diederichsen AC, Hvidsten S, Hougaard M, Junker P (2016) Cardiac abnormalities in adult patients with polymyositis or dermatomyositis as assessed by noninvasive modalities. Arthritis Care Res 68:1012–1020CrossRef
6.
Zurück zum Zitat Guerra F, Gelardi C, Capucci A, Gabrielli A, Danieli MG (2017) Subclinical cardiac dysfunction in polymyositis and dermatomyositis: a speckle-tracking case-control study. J Rheumatol 44:815–821CrossRefPubMed Guerra F, Gelardi C, Capucci A, Gabrielli A, Danieli MG (2017) Subclinical cardiac dysfunction in polymyositis and dermatomyositis: a speckle-tracking case-control study. J Rheumatol 44:815–821CrossRefPubMed
7.
Zurück zum Zitat Jasaityte R, Heyde B, D’hooge J (2013) Current state of three-dimensional myocardial strain estimation using echocardiography. J Am Soc Echocardiogr 26:15–28CrossRefPubMed Jasaityte R, Heyde B, D’hooge J (2013) Current state of three-dimensional myocardial strain estimation using echocardiography. J Am Soc Echocardiogr 26:15–28CrossRefPubMed
8.
Zurück zum Zitat Schwartz T, Sanner H, Gjesdal O, Flatø B, Sjaastad I (2014) In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity. Ann Rheum Dis 73:1805–1810CrossRefPubMed Schwartz T, Sanner H, Gjesdal O, Flatø B, Sjaastad I (2014) In juvenile dermatomyositis, cardiac systolic dysfunction is present after long-term follow-up and is predicted by sustained early skin activity. Ann Rheum Dis 73:1805–1810CrossRefPubMed
9.
Zurück zum Zitat Song FY, Shi J, Guo Y, Zhang CJ, Xu YC, Zhang QL et al (2017) Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy. Int J Cardiovasc Imaging 33:857–868CrossRefPubMed Song FY, Shi J, Guo Y, Zhang CJ, Xu YC, Zhang QL et al (2017) Assessment of biventricular systolic strain derived from the two-dimensional and three-dimensional speckle tracking echocardiography in lymphoma patients after anthracycline therapy. Int J Cardiovasc Imaging 33:857–868CrossRefPubMed
10.
Zurück zum Zitat Bossone E, D’Andrea A, D’Alto M, Citro R, Argiento P, Ferrara F et al (2013) Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr 26:1–14CrossRefPubMed Bossone E, D’Andrea A, D’Alto M, Citro R, Argiento P, Ferrara F et al (2013) Echocardiography in pulmonary arterial hypertension: from diagnosis to prognosis. J Am Soc Echocardiogr 26:1–14CrossRefPubMed
11.
Zurück zum Zitat Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347CrossRefPubMed Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (first of two parts). N Engl J Med 292:344–347CrossRefPubMed
12.
Zurück zum Zitat Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407CrossRefPubMed Bohan A, Peter JB (1975) Polymyositis and dermatomyositis (second of two parts). N Engl J Med 292:403–407CrossRefPubMed
13.
Zurück zum Zitat Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N et al (2011) Measures of adult and juvenile dermatomyositis,polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res 63(Suppl 11):S118–S157CrossRef Rider LG, Werth VP, Huber AM, Alexanderson H, Rao AP, Ruperto N et al (2011) Measures of adult and juvenile dermatomyositis,polymyositis, and inclusion body myositis: Physician and Patient/Parent Global Activity, Manual Muscle Testing (MMT), Health Assessment Questionnaire (HAQ)/Childhood Health Assessment Questionnaire (C-HAQ), Childhood Myositis Assessment Scale (CMAS), Myositis Disease Activity Assessment Tool (MDAAT), Disease Activity Score (DAS), Short Form 36 (SF-36), Child Health Questionnaire (CHQ), physician global damage, Myositis Damage Index (MDI), Quantitative Muscle Testing (QMT), Myositis Functional Index-2 (FI-2), Myositis Activities Profile (MAP), Inclusion Body Myositis Functional Rating Scale (IBMFRS), Cutaneous Dermatomyositis Disease Area and Severity Index (CDASI), Cutaneous Assessment Tool (CAT), Dermatomyositis Skin Severity Index (DSSI), Skindex, and Dermatology Life Quality Index (DLQI). Arthritis Care Res 63(Suppl 11):S118–S157CrossRef
14.
Zurück zum Zitat Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 1:1–39CrossRef Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L et al (2015) Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 1:1–39CrossRef
15.
Zurück zum Zitat Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17:1321–1360CrossRefPubMed Nagueh SF, Smiseth OA, Appleton CP, Byrd BF, Dokainish H, Edvardsen T et al (2016) Recommendations for the evaluation of left ventricular diastolic function by echocardiography: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging 17:1321–1360CrossRefPubMed
16.
Zurück zum Zitat Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 23:685–713CrossRefPubMed Rudski LG, Lai WW, Afilalo J, Hua L, Handschumacher MD, Chandrasekaran K et al (2010) Guidelines for the echocardiographic assessment of the right heart in adults: a report from the American Society of Echocardiography. J Am Soc Echocardiogr 23:685–713CrossRefPubMed
17.
18.
Zurück zum Zitat Gupta R, Wayangankar SA, Targoff IN, Hennebry TA (2011) Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review. Int J Cardiol 148:261–270CrossRefPubMed Gupta R, Wayangankar SA, Targoff IN, Hennebry TA (2011) Clinical cardiac involvement in idiopathic inflammatory myopathies: a systematic review. Int J Cardiol 148:261–270CrossRefPubMed
19.
Zurück zum Zitat Toyota E, Ogasawara Y, Hiramatsu O, Tachibana H, Kajiya F, Yamamori S et al (2005) Dynamics of flow velocities in endocardial and epicardial coronary arterioles. Am J Physiol Heart Circ Physiol 288:H1598–H1603CrossRefPubMed Toyota E, Ogasawara Y, Hiramatsu O, Tachibana H, Kajiya F, Yamamori S et al (2005) Dynamics of flow velocities in endocardial and epicardial coronary arterioles. Am J Physiol Heart Circ Physiol 288:H1598–H1603CrossRefPubMed
20.
Zurück zum Zitat Moore CC, Lugo-Olivieri CH, McVeigh ER, Zerhouni EA (2000) Three-dimensional systolic strain patterns in the normal human left ventricle: characterization with tagged MR imaging. Radiology 214:453–466CrossRefPubMedPubMedCentral Moore CC, Lugo-Olivieri CH, McVeigh ER, Zerhouni EA (2000) Three-dimensional systolic strain patterns in the normal human left ventricle: characterization with tagged MR imaging. Radiology 214:453–466CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Reisner SA, Lysyansky P, Agmon Y, Mutlak D, Lessick J, Friedman Z (2004) Global longitudinal strain: a novel index of left ventricular systolic function. J Am Soc Echocardiogr 17:630–633CrossRefPubMed Reisner SA, Lysyansky P, Agmon Y, Mutlak D, Lessick J, Friedman Z (2004) Global longitudinal strain: a novel index of left ventricular systolic function. J Am Soc Echocardiogr 17:630–633CrossRefPubMed
22.
Zurück zum Zitat Wang J, Khoury DS, Yue Y, Torre-Amione G, Nagueh SF (2008) Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J 29:1283–1289CrossRefPubMed Wang J, Khoury DS, Yue Y, Torre-Amione G, Nagueh SF (2008) Preserved left ventricular twist and circumferential deformation, but depressed longitudinal and radial deformation in patients with diastolic heart failure. Eur Heart J 29:1283–1289CrossRefPubMed
23.
Zurück zum Zitat Schwartz T, Diederichsen LP, Lundberg IE, Sjaastad I, Sanner H (2016) Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies. RMD open 2:e000291CrossRefPubMedPubMedCentral Schwartz T, Diederichsen LP, Lundberg IE, Sjaastad I, Sanner H (2016) Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies. RMD open 2:e000291CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Limaye VS, Lester S, Blumbergs P, ROBERTS-THOMSON PJ (2010) Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus. Int J Rheum Dis 13:132–137CrossRefPubMed Limaye VS, Lester S, Blumbergs P, ROBERTS-THOMSON PJ (2010) Idiopathic inflammatory myositis is associated with a high incidence of hypertension and diabetes mellitus. Int J Rheum Dis 13:132–137CrossRefPubMed
25.
Zurück zum Zitat Lega JC, Reynaud Q, Belot A, Fabien N, Durieu I, Cottin V (2015) Idiopathic inflammatory myopathies and the lung. Eur Respir Rev 24:216–238CrossRefPubMed Lega JC, Reynaud Q, Belot A, Fabien N, Durieu I, Cottin V (2015) Idiopathic inflammatory myopathies and the lung. Eur Respir Rev 24:216–238CrossRefPubMed
26.
Zurück zum Zitat D’andrea A, Stanziola A, Di Palma E, Martino M, D’alto M, Dellegrottaglie S (2016) Right ventricular structure and function in idiopathic pulmonary fibrosis with or without pulmonary hypertension. Echocardiography 33:57–65CrossRefPubMed D’andrea A, Stanziola A, Di Palma E, Martino M, D’alto M, Dellegrottaglie S (2016) Right ventricular structure and function in idiopathic pulmonary fibrosis with or without pulmonary hypertension. Echocardiography 33:57–65CrossRefPubMed
27.
Zurück zum Zitat Kato S, Sekine A, Kusakawa Y, Ogura T, Futaki M, Iwasawa T (2015) Prognostic value of cardiovascular magnetic resonance derived right ventricular function in patients with interstitial lung disease. J Cardiovasc Magn Reson 17:10CrossRefPubMedPubMedCentral Kato S, Sekine A, Kusakawa Y, Ogura T, Futaki M, Iwasawa T (2015) Prognostic value of cardiovascular magnetic resonance derived right ventricular function in patients with interstitial lung disease. J Cardiovasc Magn Reson 17:10CrossRefPubMedPubMedCentral
28.
Zurück zum Zitat Hilde JM, Skjorten I, Grotta OJ, Hansteen V, Melsom MN, Hisdal J et al (2013) Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension. J Am Coll Cardiol 62:1103–1111CrossRefPubMed Hilde JM, Skjorten I, Grotta OJ, Hansteen V, Melsom MN, Hisdal J et al (2013) Right ventricular dysfunction and remodeling in chronic obstructive pulmonary disease without pulmonary hypertension. J Am Coll Cardiol 62:1103–1111CrossRefPubMed
29.
Zurück zum Zitat Péter A, Balogh Á, Szilágyi S, Faludi R, Nagy-Vincze M, Édes I et al (2015) Echocardiographic abnormalities in new-onset polymyositis/dermatomyositis. J Rheumatol 42:272–281CrossRefPubMed Péter A, Balogh Á, Szilágyi S, Faludi R, Nagy-Vincze M, Édes I et al (2015) Echocardiographic abnormalities in new-onset polymyositis/dermatomyositis. J Rheumatol 42:272–281CrossRefPubMed
30.
Zurück zum Zitat Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF (2011) Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 63:3439–3447CrossRefPubMed Marie I, Hatron PY, Dominique S, Cherin P, Mouthon L, Menard JF (2011) Short-term and long-term outcomes of interstitial lung disease in polymyositis and dermatomyositis: a series of 107 patients. Arthritis Rheum 63:3439–3447CrossRefPubMed
31.
Zurück zum Zitat Rider LG, Lachenbruch PA, Monroe JB, Ravelli A, Cabalar I, Feldman BM et al (2009) Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum 60:3425–3435CrossRefPubMedPubMedCentral Rider LG, Lachenbruch PA, Monroe JB, Ravelli A, Cabalar I, Feldman BM et al (2009) Damage extent and predictors in adult and juvenile dermatomyositis and polymyositis as determined with the myositis damage index. Arthritis Rheum 60:3425–3435CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Danieli MG, Gelardi C, Guerra F, Cardinaletti P, Pedini V, Gabrielli A (2016) Cardiac involvement in polymyositis and dermatomyositis. Autoimmun Rev 15:462–465CrossRefPubMed Danieli MG, Gelardi C, Guerra F, Cardinaletti P, Pedini V, Gabrielli A (2016) Cardiac involvement in polymyositis and dermatomyositis. Autoimmun Rev 15:462–465CrossRefPubMed
33.
Zurück zum Zitat Danieli MG, Gambini S, Pettinari L, Logullo F, Veronesi G, Gabrielli A (2014) Impact of treatment on survival in polymyositis and dermatomyositis: a single-centre long-term follow-up study. Autoimmun Rev 13:1048–1054CrossRefPubMed Danieli MG, Gambini S, Pettinari L, Logullo F, Veronesi G, Gabrielli A (2014) Impact of treatment on survival in polymyositis and dermatomyositis: a single-centre long-term follow-up study. Autoimmun Rev 13:1048–1054CrossRefPubMed
34.
Zurück zum Zitat Dankó K, Ponyi A, Constantin T, Borgulya G, Szegedi G (2004) Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine 83:35–42CrossRefPubMed Dankó K, Ponyi A, Constantin T, Borgulya G, Szegedi G (2004) Long-term survival of patients with idiopathic inflammatory myopathies according to clinical features: a longitudinal study of 162 cases. Medicine 83:35–42CrossRefPubMed
35.
Zurück zum Zitat Haupt HM, Hutchins GM (1982) The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol 50:998–1006CrossRefPubMed Haupt HM, Hutchins GM (1982) The heart and cardiac conduction system in polymyositis-dermatomyositis: a clinicopathologic study of 16 autopsied patients. Am J Cardiol 50:998–1006CrossRefPubMed
Metadaten
Titel
Cardiac function in patients with polymyositis or dermatomyositis: a three-dimensional speckle-tracking echocardiography study
verfasst von
Yue Zhong
Wenjuan Bai
Qibing Xie
Jianhong Sun
Hong Tang
Li Rao
Publikationsdatum
22.11.2017
Verlag
Springer Netherlands
Erschienen in
The International Journal of Cardiovascular Imaging / Ausgabe 5/2018
Print ISSN: 1569-5794
Elektronische ISSN: 1875-8312
DOI
https://doi.org/10.1007/s10554-017-1278-9

Weitere Artikel der Ausgabe 5/2018

The International Journal of Cardiovascular Imaging 5/2018 Zur Ausgabe

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Strenge Blutdruckeinstellung lohnt auch im Alter noch

30.04.2024 Arterielle Hypertonie Nachrichten

Ältere Frauen, die von chronischen Erkrankungen weitgehend verschont sind, haben offenbar die besten Chancen, ihren 90. Geburtstag zu erleben, wenn ihr systolischer Blutdruck < 130 mmHg liegt. Das scheint selbst für 80-Jährige noch zu gelten.

Sind Frauen die fähigeren Ärzte?

30.04.2024 Gendermedizin Nachrichten

Patienten, die von Ärztinnen behandelt werden, dürfen offenbar auf bessere Therapieergebnisse hoffen als Patienten von Ärzten. Besonders gilt das offenbar für weibliche Kranke, wie eine Studie zeigt.

Dihydropyridin-Kalziumantagonisten können auf die Nieren gehen

30.04.2024 Hypertonie Nachrichten

Im Vergleich zu anderen Blutdrucksenkern sind Kalziumantagonisten vom Diyhdropyridin-Typ mit einem erhöhten Risiko für eine Mikroalbuminurie und in Abwesenheit eines RAS-Blockers auch für ein terminales Nierenversagen verbunden.

Update Kardiologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.